Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:58 PM ET 8-K
Shareholder Meeting Fact II Acquisition Corp. FACT

Fact II Acquisition Shareholder Meeting

FACT II Acquisition Corp. has postponed its extraordinary general meeting of shareholders from November 10, 2026, to November 17, 2026. The meeting is intended to vote on an extension amendment proposal to move the company's business combination deadline to November 25, 2027.

4:58 PM ET 10-Q
Financial Results Innovex International, Inc. INVX

Innovex International Q3 2026 Results: Net Income $26.3M, Down 33.0% YoY

Innovex International reported total revenues of $749.0 million for the nine months ended September 30, 2026, compared to $704.6 million in the prior year period. The company's balance sheet shows a significant new $53.4 million legal settlement accrual and an increase in goodwill and intangibles following merger and acquisition activities.

Key figure
Net income $26.3M · -33.0% YoY
4:58 PM ET 10-Q
Financial Results Wintrust Financial Corp WTFC

Wintrust Financial Q3 2026 Results: Net Income $239M, Up 10.5% YoY

Wintrust Financial Corp reported net income of $239.1 million for the third quarter of 2026, up from $216.3 million in the prior year period, driven by higher net interest income. Total assets grew to $76.0 billion as of September 30, 2026, while the company experienced a significant increase in accumulated other comprehensive loss due to unrealized losses on available-for-sale securities and derivative instruments.

Key figure
Net income $239M · +10.5% YoY
4:58 PM ET 8-K
Financial Results Beyond Meat, Inc. BYND

Beyond Meat Financial Results

Beyond Meat reported Q3 2026 financial results with net revenues of $64.5 million, representing an 8.1% year-over-year decrease. Despite the revenue decline, the company achieved its highest gross margin in five years at 19.3% and narrowed its Adjusted EBITDA loss to $24.6 million.

Term
Q3 2026

“Our third quarter results represent measurable progress. Total net revenues came in at the high end of our guidance range, gross margin was our highest in five years, Adjusted EBITDA loss narrowed and we used less cash year-over year.”

Ethan Brown, President and CEO

“Our international retail channel registered a third consecutive quarter of growth, led by strong performance in Europe. More broadly, we believe we are taking the right steps as we pursue stabilization of U.S. revenues while aggressively driving enterprise-wide cost reduction, including through actions taken in the quarter to substantially reduce certain long-term lease obligations.”

Ethan Brown, President and CEO
4:58 PM ET 10-Q
Financial Results United Community Banks Inc UCB

United Community Banks Q3 2026 Results: Net Loss of $140M

United Community Banks, Inc. filed its 10-Q for the period ending September 30, 2026, highlighting the acquisition of Peach State Bancshares and the sale of its equipment financing subsidiary, Navitas. The company reported 119,593,464 shares of common stock outstanding as of October 31, 2026, and is currently repositioning its investment securities portfolio.

Key figure
Net loss $140M
4:58 PM ET 8-K
Dividend Vse Corp VSEC

Vse Dividend

VSE Corporation's Board of Directors declared a regular quarterly cash dividend of $0.10 per share of common stock. The dividend is scheduled to be paid on January 29, 2027, to stockholders of record as of the close of business on January 15, 2027.

4:58 PM ET 10-Q
Financial Results Evolus, Inc. EOLS ▶ Call

Evolus Q3 2026 Results: Net Loss of $12.5M, Loss Narrows

Evolus, Inc. is an aesthetic neurotoxin company that has incurred significant losses since inception and relies heavily on its licensing agreements with Daewoong and Symatese. The company is currently focused on the commercial success of Jeuveau and the regulatory approval process for its Evolysse product line.

Key figure
Net loss $12.5M
4:58 PM ET Form 4
Insider Selling Xeris Biopharma Holdings, Inc. XERS

Xeris Biopharma Holdings Insider Beth Hecht Sells $256K of Stock

Beth Hecht sold 25,000 shares of Xeris Biopharma Holdings, Inc. at $10.23 a share, worth $256K in total on Nov 2, 2026. Shares held after the trade: 1,086,130 (-2.2%).

Value
$256K
Shares
25,000
Price
$10.23
Holding change
-2.2%
Trade date
Nov 2, 2026
4:57 PM ET Form 4
Insider Buying Jetblue Airways Corp JBLU

Jetblue Airways Insider Nik Mittal Buys $324K of Stock

Nik Mittal bought 100,000 shares of Jetblue Airways Corp at $3.23 to $3.24 a share (average $3.24) in 2 transactions, worth $324K in total on Nov 3, 2026. Shares held after the trade: 238,537 (+40.5%).

Value
$324K
Shares
100,000
Average price
$3.24
Holding change
+40.5%
Trade date
Nov 3, 2026
4:57 PM ET Form 4
Insider Selling Xeris Biopharma Holdings, Inc. XERS

Xeris Biopharma Holdings Insider Kevin McCulloch Sells $153K of Stock

Kevin McCulloch sold 15,000 shares of Xeris Biopharma Holdings, Inc. at $10.23 a share, worth $153K in total on Nov 2, 2026. Shares held after the trade: 1,584,208 (-0.9%).

Value
$153K
Shares
15,000
Price
$10.23
Holding change
-0.9%
Trade date
Nov 2, 2026
4:57 PM ET 10-Q
Financial Results Great Elm Group, Inc. GEG

Great Elm Group Q1 2026 Results: Net Loss of $4.15M, Loss Narrows

Great Elm Group, Inc. reported a net loss of $4.1 million for the quarter ended September 30, 2026, compared to a $7.9 million loss in the prior year period. Total revenues decreased significantly to $3.3 million from $10.8 million, while the company maintained a cash balance of $43.2 million and total assets of $110.0 million.

Key figure
Net loss $4.15M
4:56 PM ET 8-K
Investor Presentation Independent Bank Corp IBCP

Independent Bank Investor Presentation

Independent Bank Corporation management is presenting at the HOVDE Group Financial Services Conference on November 5, 2026. The company filed a formal investor presentation deck as an exhibit, highlighting its $6.3 billion in total assets and its market position in Michigan.

4:56 PM ET 8-K
Financial Results Matrix Service Co MTRX

Matrix Service Financial Results

Matrix Service Company reported its third consecutive quarter of profitability for the fiscal 2027 first quarter, with revenue increasing to $219.4 million. The company achieved a net income of $6.2 million compared to a net loss in the prior year, driven by organic growth in storage, terminal solutions, and mining activity. Management highlighted a strong liquidity position of $221.8 million with zero outstanding debt.

Term
Q1 2027

“Our first quarter results reflect the continued execution of our WIN, EXECUTE, DELIVER strategy and demonstrate the progress we are making to position Matrix for sustainable, profitable growth.”

Shawn P. Payne, President and Chief Executive Officer

“Our third consecutive quarter of profitability, coupled with meaningful Adjusted EBITDA margin expansion, reflects the structural changes we have made over the past 18 months to improve execution, create a more efficient operating model, and drive more consistent profitability as we grow.”

Shawn P. Payne, President and Chief Executive Officer
4:56 PM ET 10-Q
Financial Results Red Violet, Inc. RDVT

Red Violet Q3 2026 Results: Net Income $5.45M, Up 29.2% YoY

Red Violet, Inc. reported strong growth for the third quarter of 2026, with revenue increasing 20% to $27.8 million and net income rising to $5.4 million. The company significantly strengthened its balance sheet through an underwritten public offering that raised $108.7 million, contributing to a total asset base of $237.9 million as of September 30, 2026.

Key figure
Net income $5.45M · +29.2% YoY
4:55 PM ET 10-Q
Financial Results Hamilton Beach Brands Holding Co HBB

Hamilton Beach Brands Holding Q3 2026 Results: Net Income $3.54M, Up 114.3% YoY

Hamilton Beach Brands Holding Company reported a significant increase in net income for the nine months ended September 30, 2026, reaching $40.8 million compared to $7.9 million in the prior year. This growth was driven by improved gross profit margins and a reduction in cost of sales, while the company also strengthened its cash position to $92.5 million.

Key figure
Net income $3.54M · +114.3% YoY
4:55 PM ET Form 4
Insider Selling Sunrun Inc. RUN

Sunrun CAO Maria Barak Sells $30.4K of Stock

Maria Barak, CAO, sold 3,256 shares of Sunrun Inc. at $9.35 a share, worth $30.4K in total on Nov 4, 2026. Shares held after the trade: 85,006 (-3.7%).

Value
$30.4K
Shares
3,256
Price
$9.35
Role
CAO
Holding change
-3.7%
Trade date
Nov 4, 2026
4:55 PM ET 10-Q
Financial Results Energy Fuels Inc UUUU

Energy Fuels Q3 2027 Results

Energy Fuels Inc. reported a net loss of $96.93 million for the nine months ended September 30, 2026, compared to a $65.17 million loss in the prior year, despite revenues increasing significantly to $90.13 million. The company's balance sheet was bolstered by the acquisition of ASM and significant equity raises through its at-the-market offering program, resulting in total assets of $1.72 billion.

4:55 PM ET Form 4
Insider Selling SI-BONE, Inc. SIBN

SI-BONE Director Jeffrey W. Dunn Sells $418K of Stock

Jeffrey W. Dunn, Director, sold 20,000 shares of SI-BONE, Inc. at $20.89 a share, worth $418K in total on Nov 2, 2026. Shares held after the trade: 16,057 (-55.5%).

Value
$418K
Shares
20,000
Price
$20.89
Role
Director
Holding change
-55.5%
Trade date
Nov 2, 2026
4:54 PM ET Form 4
Insider Selling Arthur J. Gallagher & Co. AJG

Arthur J. Gallagher & VP Christopher E. Mead Sells $2.12M of Stock

Christopher E. Mead, VP, sold 7,590 shares of Arthur J. Gallagher & Co. at $279.72 a share, worth $2.12M in total on Nov 2, 2026. Shares held after the trade: 22,287 (-25.4%).

Value
$2.12M
Shares
7,590
Price
$279.72
Role
VP
Holding change
-25.4%
Trade date
Nov 2, 2026
4:54 PM ET 10-Q
Financial Results United Parcel Service Inc UPS

United Parcel Service Q3 2026 Results: Net Income $1.16B, Down 11.3% YoY

For the nine months ended September 30, 2026, UPS reported revenue of $66.9 billion, an increase from $64.2 billion in the prior year, though net income decreased to $2.6 billion from $3.8 billion due to higher operating expenses. Operating profit was impacted by significant increases in purchased transportation and fuel costs, as well as transformation strategy costs.

Key figure
Net income $1.16B · -11.3% YoY
4:54 PM ET 10-Q
Financial Results Mgt Capital Investments, Inc. MGTI

Mgt Capital Investments Q3 2026 Results: Net Loss of $171K, Loss Narrows

MGT Capital Investments reported zero revenue for the nine months ended September 30, 2026, following the discontinuation of its Bitcoin mining and hosting operations in 2025. The company realized a net loss of $3.1 million for the period, primarily driven by a $2.8 million loss on debt extinguishment related to a note exchange agreement.

Key figure
Net loss $171K
4:53 PM ET 10-Q
Financial Results Belpointe PREP, LLC OZ

Belpointe PREP Q3 2026 Results: Net Loss of $8.7M, Loss Narrows

Belpointe PREP, LLC reported a net loss of $28.6 million for the nine months ended September 30, 2026, compared to a $28.4 million loss in the prior year. While rental revenue increased significantly to $15.9 million from $6.1 million, the company faced higher interest and property expenses as it continues to develop and stabilize its real estate portfolio.

Key figure
Net loss $8.7M
4:53 PM ET 10-Q
Financial Results International Paper Co IP

International Paper Q3 2026 Results: Net Loss of $1.13B, Loss Widens

International Paper completed the sale of its Global Cellulose Fibers business in early 2026 and is currently pursuing a separation of its Packaging Solutions EMEA business. For the nine months ended September 30, 2026, the company reported total net sales of $18.17 billion, a slight increase from $17.63 billion in the prior year period, despite a comprehensive loss of $994 million.

Key figure
Net loss $1.13B
4:52 PM ET Form 4
Insider Selling Hershey Co HSY

Hershey Insider Hershey Trust Co Trustee in Trust for Milton Hershey School Sells $5.12M of Stock

Hershey Trust Co Trustee in Trust for Milton Hershey School sold 30,000 shares of Hershey Co at $165.79 to $175.16 a share (average $170.63) in 17 transactions, worth $5.12M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 436,119 (-0.4%).

Value
$5.12M
Shares
30,000
Average price
$170.63
Holding change
-0.4%
Trade date
Nov 2, 2026 to Nov 4, 2026
4:52 PM ET Form 4
Insider Selling Vaxcyte, Inc. PCVX

Vaxcyte SVP, Finance & CAO Elvia Cowan Sells $183K of Stock

Elvia Cowan, SVP, Finance & CAO, sold 3,000 shares of Vaxcyte, Inc. at $60.77 to $61.55 a share (average $60.92) in 2 transactions, worth $183K in total on Nov 2, 2026. Shares held after the trade: 27,860 (-2.1%).

Value
$183K
Shares
3,000
Average price
$60.92
Role
SVP, Finance & CAO
Holding change
-2.1%
Trade date
Nov 2, 2026
4:52 PM ET Form 4
Insider Selling Miami International Holdings, Inc. MIAX

Miami International Holdings EVP, GC & Corporate Secretary Barbara J. Comly Sells $2.78M of Stock

Barbara J. Comly, EVP, GC & Corporate Secretary, sold 79,361 shares of Miami International Holdings, Inc. at $35.07 to $35.10 a share (average $35.08) in 2 transactions, worth $2.78M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 839,564 (-6.3%).

Value
$2.78M
Shares
79,361
Average price
$35.08
Role
EVP, GC & Corporate Secretary
Holding change
-6.3%
Trade date
Nov 2, 2026 to Nov 4, 2026
4:52 PM ET 8-K
Financial Results Summit Therapeutics Inc. SMMT

Summit Therapeutics Financial Results

Summit Therapeutics reported its Q3 2026 financial results, highlighting a $2.0 billion strategic equity investment from AstraZeneca received post-quarter. The company ended the period with $629.8 million in cash and is advancing its global clinical development program for ivonescimab across multiple solid tumor indications.

“This quarter marked a period of meaningful momentum for Summit, highlighted by AstraZeneca’s $2 billion strategic equity investment and the expansion of our network of clinical collaborations with AstraZeneca, Daiichi Sankyo, and several others.”

Robert W. Duggan, Chairman and Co-Chief Executive Officer of Summit

“Our global clinical development program for ivonescimab continues to broaden, with the announcement of ivonescimab combination collaborations with Datroway® and sone-ve, alongside new studies in bladder cancer with HARMONi-GU1, in biliary tract cancer with EA2251, and in kidney cancer with SMT112-216 and Arcus’ ARC- 20 platform study.”

Dr. Maky Zanganeh, President and Co-Chief Executive Officer of Summit
4:52 PM ET 8-K
Stock Buyback CBL & Associates Properties Inc CBL

CBL & Associates Properties Announces $25M Stock Buyback

CBL Properties' Board of Directors authorized a new $25.0 million common stock repurchase program to replace its existing program. The company intends to buy back shares on the open market or through private transactions through December 31, 2027, citing a belief that its shares are currently undervalued relative to its portfolio quality and cash flow.

Value
$25M
Term
through Dec 31, 2027
4:52 PM ET Form 4
Insider Selling Vaxcyte, Inc. PCVX

Vaxcyte EVP, Chief Scientific Ofc, COO Jim Wassil Sells $137K of Stock

Jim Wassil, EVP, Chief Scientific Ofc, COO, sold 2,250 shares of Vaxcyte, Inc. at $60.78 to $61.57 a share (average $60.90) in 2 transactions, worth $137K in total on Nov 2, 2026. Shares held after the trade: 145,435 (-0.2%).

Value
$137K
Shares
2,250
Average price
$60.90
Role
EVP, Chief Scientific Ofc, COO
Holding change
-0.2%
Trade date
Nov 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.